echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Neurol: The relationship between white matter hyperintensity and the pathology and progression of Parkinson's disease in the elderly

    JAMA Neurol: The relationship between white matter hyperintensity and the pathology and progression of Parkinson's disease in the elderly

    • Last Update: 2021-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Parkinson's disease (PD) is one of the most common neurodegenerative diseases, characterized by bradykinesia, resting tremor, stiffness, and postural instability
    .


    Parkinson's disease is not benign because it is associated with many adverse health consequences, including disability, falls, dementia, and death


    Parkinson's disease (PD) is one of the most common neurodegenerative diseases, characterized by bradykinesia, resting tremor, stiffness, and postural instability


    Although Parkinson's disease is very common in the elderly, its pathological basis is still controversial


    There are few longitudinal studies on the relationship between brain imaging or autopsy of cerebrovascular disease pathology and progressive Parkinson's disease in the elderly


    Recently, some researchers have examined neurodegenerative diseases (including Parkinson's disease and cerebrovascular disease) to confirm whether the burden of white matter high intensity (WMH) is related to the incidence of progressive Parkinson's disease


    This community-based cohort study included participants recruited from three ongoing cohorts registered in 1994, 1997, and 2004
    .


    Before death, participants received an average of 7.


    This community-based cohort study included participants recruited from three ongoing cohorts registered in 1994, 1997, and 2004


    The modified Fazekas rating scale was used to assess WMH load


    The 26 items in the revised exercise part of the Unified Parkinson's Disease Rating Scale areused to evaluate Parkinson's disease every year


    • Among the 516 deaths, 364 (70.
      5%) were women, and the average age of death was 90.
      2 years (6.
      4 years)
      .
    • The higher the body mass index, the faster the progression of Parkinson's disease (estimated 0.
      024; SE 0.
      008; P=0.
      002)
      .
    • When controlling the pathological indicators of cerebrovascular disease, the decrease of this correlation is greater than when controlling neurodegenerative diseases (Cerebrovascular disease: estimated, 0.
      019; SE, 0.
      008; P=0.
      02; neurodegenerative: estimated, 0.
      022; SE , 0.
      008; P=0.
      003), but the two are still significant
      .
  • Among the 516 deaths, 364 (70.
    5%) were women, and the average age of death was 90.
    2 years (6.
    4 years)
    .
  • Among the 516 deaths, 364 (70.
    5%) were women, and the average age of death was 90.
    2 years (6.
    4 years)
    .


  • The higher the body mass index, the faster the progression of Parkinson's disease (estimated 0.


         In this cohort study, higher levels of WMH and cerebrovascular disease pathological indexes in the brains of the elderly were associated with more rapidly progressive Parkinson's disease


    Literature source: https://jamanetwork-com.
    fjny.
    80599.
    net/journals/jamaneurology/article-abstract/2785851 https://jamanetwork-com.
    fjny.
    80599.
    net/journals/jamaneurology/article-abstract/2785851 in This message
  • This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.